Cold Chain Logistics in Clinical Trials | January 2023 GLSA Networking Event
Cold chain logistics in clinical trials was the focus of the January 18, 2023 FOCM | GLSA Networking Event. To begin, attendees were welcomed and wished a Happy New Year as the group gathered for the first event of the year. At the same time, GLSA shared how these sessions are structured to encourage open dialogue, flexibility, and meaningful industry connections.
Cold Chain Logistics in Clinical Trials: Event Format and Guidelines
As a reminder, GLSA networking events are designed as open-house sessions. In practice, this means attendees are welcome to drop in when they can and leave when needed. Additionally, presenters typically begin once a strong group has assembled, usually 10–15 minutes after the scheduled start time. Importantly, presentations are not sales pitches but instead focus on specific aspects of clinical trials and where services fit within the development process.
To stay informed, attendees were encouraged to sign up for the GLSA newsletter and notifications about future live and virtual events:
👉 http://bit.ly/3UTb8hL
Finally, to support ongoing collaboration, everyone was asked to share their LinkedIn profile in the chat to make follow-up and networking easier.
Industry Updates Impacting Cold Chain Logistics in Clinical Trials
Before transitioning to the main topic, the group shared recent industry updates, news, and informal discussion points. From there, the conversation shifted to the evening’s featured topic: cold chain logistics in clinical trials.
Loretta Cipkus Dubray opened the presentation with an overview of cold chain shipment management. Specifically, she outlined key temperature categories—ambient, refrigerated, frozen, and sub-zero—and reviewed regulatory expectations for managing temperature excursions. In addition, real-world examples highlighted the financial and product losses that can occur when temperature control fails.
Cold Chain Solutions in Practice
Building on this foundation, Rafa Martin-Alos and Victor Camacho explained how CoolChain’s products support temperature control across all categories. Notably, their shipping solutions can maintain required temperatures for up to 120 hours. As a result, refrigerated truck containers are not always necessary, and products with different temperature requirements can be shipped together safely
Closing and Key Takeaway
Overall, the discussion reinforced why cold chain logistics in clinical trials is essential for protecting biologic materials, ensuring regulatory compliance, and safeguarding patient outcomes. Ultimately, events like this highlight the value of shared expertise and practical solutions within the clinical research community.
January 2023 Attendees – Cold Chain Logistics in Clinical Trials Discussion
Industry Participants
-
Rafa Martin-Alos – Cool Chain
-
Victor Camacho – Cool Chain
-
Loretta Cipkus Dubray – Global Clinical Connections
-
Joseph Cheng – PiVOT
-
Mike O’Gorman – Life Science Marketplace
-
Brian Langin – Diligent Pharma
-
Liz Mirra – Mirraponte
-
Ori Geshury – Mirraponte
-
Duncan Shaw – DTS Language Services
-
Scott Robertson – Mednet
-
Griffin Robertson – Mednet
-
Jeff Page – Consultant
-
Kate Mullis – ICON
GLSA Team
-
Denise McNerney
-
Chris Matheus
-
Joe Buser
-
Charity Dube
-
Hannah Lloyd
-
Sally Haller
-
Daryl Oberg
-
Holly Cliffe
-
Timmina Williams
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.
